Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: A randomized controlled trial

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Ljótsson, Brjánn ^a   Andersson, Gerhard ^a,b   Andersson, Erik ^a   Hedman, Erik ^a   Lindfors, Perjohan ^c   Andréewitch, Sergej ^a   Rück, Christian ^a   Lindefors, Nils ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Sabbatsberg Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEAR; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERNET; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT PLANNING;

EID: 80053897422     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-110     Document Type: Article

References (65)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130(5):1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.
2. Halder SL, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004, 19(2):233-242. 10.1111/j.0269-2813.2004.01807.x, 14723614.
3. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2008, 103(5):1229-1239. quiz 1240, 10.1111/j.1572-0241.2007.01740.x, 18371141.
4. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000, 95(1):67-71. 10.1111/j.1572-0241.2000.01735.x, 10638561.
5. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38(9):1569-1580. 10.1007/BF01303162, 8359066.
6. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995, 109(6):1736-1741. 10.1016/0016-5085(95)90738-6, 7498636.
7. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007, 56(12):1770-1798. 10.1136/gut.2007.119446, 2095723, 17488783.
8. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122(5):1500-1511. 10.1053/gast.2002.32978, 11984534.
9. Mayer EA. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008, 358(16):1692-1699. 10.1056/NEJMcp0801447, 18420501.
10. Hungin AP. Self-help interventions in irritable bowel syndrome. Gut 2006, 55(5):603-604. 10.1136/gut.2005.075606, 1856125, 16609132.
11. Andersson G. Using the Internet to provide cognitive behaviour therapy. Behav Res Ther 2009, 47(3):175-180. 10.1016/j.brat.2009.01.010, 19230862.
12. Bergström J, Andersson G, Ljótsson B, Rück C, Andréewitch S, Karlsson A, Carlbring P, Andersson E, Lindefors N. Internet- versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial. BMC Psychiatry 2010, 10(1):54. 10.1186/1471-244X-10-54, 2910662, 20598127.
13. Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, Mörtberg E, Lindefors N. Internet-Based Cognitive Behavior Therapy vs. Cognitive Behavioral Group Therapy for Social Anxiety Disorder: A Randomized Controlled Non-inferiority Trial. PLoS ONE 2011, 6(3):e18001. 10.1371/journal.pone.0018001, 3070741, 21483704.
14. Ljótsson B, Falk L, Wibron Vesterlund A, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome - a randomized controlled trial. Behav Res Ther 2010, 48(6):531-539. 10.1016/j.brat.2010.03.003, 20362976.
15. Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G. Internet-Delivered Exposure-Based Treatment vs. Stress Management for Irritable Bowel Syndrome: A Randomized Trial. Am J Gastroenterol 2011, 106(8):1481-1491. 10.1038/ajg.2011.139, 21537360.
16. Ljótsson B, Hedman E, Lindfors P, Hursti T, Lindefors N, Andersson G, Rück C. Long-term follow up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther 2011, 49:58-61. 10.1016/j.brat.2010.10.006, 21092934.
17. Andersson E, Ljótsson B, Smit F, Paxling B, Hedman E, Lindefors N, Andersson G, Rück C. Cost-effectiveness of internet-based cognitive behavior therapy for Irritable Bowel Syndrome: Results from a randomized controlled trial. BMC Public Health 2011, 11(1):215. 10.1186/1471-2458-11-215, 3083356, 21473754.
18. Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome - An open pilot study. J Behav Ther Exp Psychiatry 2010, 41(3):185-190. 10.1016/j.jbtep.2010.01.001, 20079485.
19. Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol Med 2010, 40(1):85-94. 10.1017/S0033291709990195, 19531276.
20. Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol 2009, 104(12):3004-3014. 10.1038/ajg.2009.479, 2804069, 19690523.
21. Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther 2009, 47:797-802. 10.1016/j.brat.2009.05.002, 19570525.
22. Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol 2008, 6(8):899-906. 10.1016/j.cgh.2008.03.004, 2630498, 18524691.
23. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148(4):295-309.
24. Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med 2007, 69(1):89-98. 10.1097/PSY.0b013e31802e2f24, 17244851.
25. Almy TP, Tulin M. Alterations in colonic function in man under stress; experimental production of changes simulating the irritable colon. Gastroenterology 1947, 8(5):616-626.
26. Mogg K, Mathews A, Bird C, Macgregor-Morris R. Effects of stress and anxiety on the processing of threat stimuli. J Pers Soc Psychol 1990, 59(6):1230-1237.
27. Hazlett-Stevens H, Craske MG, Mayer EA, Chang L, Naliboff BD. Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety. J Psychosom Res 2003, 55(6):501-505. 10.1016/S0022-3999(03)00019-9, 14642979.
28. Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, Naliboff BD. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther 2004, 20(1):89-97. 10.1111/j.1365-2036.2004.02007.x, 15456470.
29. Jerndal P, Ringstrom G, Agerforz P, Karpefors M, Akkermans LM, Bayati A, Simren M. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil 2010, 22(6):646-e179. 10.1111/j.1365-2982.2010.01493.x, 20367800.
30. Reme SE, Darnley S, Kennedy T, Chalder T. The development of the irritable bowel syndrome-behavioral responses questionnaire. J Psychosom Res 2010, 69(3):319-325. 10.1016/j.jpsychores.2010.01.025, 20708455.
31. Hayes SC. Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. Behav Ther 2004, 35(4):639-665.
32. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003, 98(10):2209-2218. 10.1111/j.1572-0241.2003.07716.x, 14572570.
33. Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 2011, 49(6-7):413-421. 10.1016/j.brat.2011.04.001, 21565328.
34. Hayes SC, Villatte M, Levin M, Hildebrandt M. Open, aware, and active: contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annu Rev Clin Psychol 2011, 7:141-168. 10.1146/annurev-clinpsy-032210-104449, 21219193.
35. Kearney DJ, McDermott K, Martinez M, Simpson TL. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life. Alimentary Pharmacology & Therapeutics 2011,
36. Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE. Mindfulness Training Reduces the Severity of Irritable Bowel Syndrome in Women: Results of a Randomized Controlled Trial. Am J Gastroenterol 2011,
37. Chiesa A, Malinowski P. Mindfulness-based approaches: are they all the same?. J Clin Psychol 2011, 67(4):404-424. 10.1002/jclp.20776, 21254062.
38. Lynch TR, Chapman AL, Rosenthal MZ, Kuo JR, Linehan MM. Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations. J Clin Psychol 2006, 62(4):459-480. 10.1002/jclp.20243, 16470714.
39. Winzelberg AJ, Classen C, Alpers GW, Roberts H, Koopman C, Adams RE, Ernst H, Dev P, Taylor CB. Evaluation of an internet support group for women with primary breast cancer. Cancer 2003, 97(5):1164-1173. 10.1002/cncr.11174, 12599221.
40. Hedman E, Ljótsson B, Rück C, Furmark T, Carlbring P, Lindefors N, Andersson G. Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation. Computers in Human Behavior 2010, 26:736-740.
41. Ritter P, Lorig K, Laurent D, Matthews K. Internet versus mailed questionnaires: a randomized comparison. J Med Internet Res 2004, 6(3):e29. 10.2196/jmir.6.3.e29, 1550608, 15471755.
42. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, Peacock RA, Wilson IK, Naesdal J. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003, 38(9):947-954. 10.1080/00365520310004209, 14531531.
43. Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995, 30(11):1046-1052. 10.3109/00365529509101605, 8578162.
44. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005, 100(5):1174-1184. 10.1111/j.1572-0241.2005.40674.x, 15842596.
45. Haakart-van Roijen L. Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness. 2002, Rotterdam: Institute for Medical Technology Assessment.
46. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998, 43(2):400-411. 10.1023/A:1018831127942, 9512138.
47. Sheehan DV. The Sheehan Disability Scales. The Anxiety Disease and How to Overcome It 1983, 151. New York: Charles Scribner and Sons.
48. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997, 27(2):93-105. 10.2190/T8EM-C8YH-373N-1UWD, 9565717.
49. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data 2000, New York: Springer.
50. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004, 61(3):310-317. 10.1001/archpsyc.61.3.310, 14993119.
51. Salim A, Mackinnon A, Christensen H, Griffiths K. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates. Psychiatry Res 2008, 160(3):335-345. 10.1016/j.psychres.2007.08.005, 18718673.
52. Little RJA, Rubin DB. Statistical analysis with missing data. 2002, Hoboken, N.J.: Wiley, 2.
53. Drummond MF, Sculpher MJ, Torrance GW. Methods for the economic evaluation of health care programmes. 2005, Oxford University Press, USA.
54. Smit F, Willemse G, Koopmanschap M, Onrust S, Cuijpers P, Beekman A. Cost-effectiveness of preventing depression in primary care patients: randomised trial. The British journal of psychiatry: the journal of mental science 2006, 188:330-336.
55. Organisation for economic co-operation and development: PPPs and exchange rates. , http://www.oecd.org
56. Efron B, Tibshirani R. An introduction to the bootstrap. 1993, New York: Chapman & Hall.
57. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992, 116(12 Pt 1):1009-1016.
58. Reme SE, Stahl D, Kennedy T, Jones R, Darnley S, Chalder T. Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome. Psychol Med 2011, 1-11.
59. Reme SE, Kennedy T, Jones R, Darnley S, Chalder T. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care. J Psychosom Res 2010, 68(4):385-388. 10.1016/j.jpsychores.2010.01.003, 20307706.
60. Jones MP, Bratten J, Keefer L. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. Am J Gastroenterol 2007, 102(10):2232-2237. 10.1111/j.1572-0241.2007.01444.x, 17680842.
61. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996, 91(2):277-283.
62. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003, 125(1):19-31. 10.1016/S0016-5085(03)00669-3, 12851867.
63. Blanchard EB, Lackner JM, Sanders K, Krasner S, Keefer L, Payne A, Gudleski GD, Katz L, Rowell D, Sykes M, et al. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther 2007, 45(4):633-648. 10.1016/j.brat.2006.07.003, 16979581.
64. Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N, Rigby C, Thompson D, Tomenson B. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003, 124(2):303-317. 10.1053/gast.2003.50055, 12557136.
65. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010, 5(12):e15591. 10.1371/journal.pone.0015591, 3008733, 21203519.